1. Home
  2. CLGN vs NEXR Comparison

CLGN vs NEXR Comparison

Compare CLGN & NEXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.35

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

NEXR

Nexera Technologies Ltd Ordinary Shares

N/A

Current Price

$0.64

Market Cap

4.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
CLGN
NEXR
Founded
2004
N/A
Country
Israel
Israel
Employees
39
38
Industry
Industrial Specialties
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.2M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
CLGN
NEXR
Price
$0.35
$0.64
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
73.6K
25.9M
Earning Date
05-27-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$240.45
N/A
Revenue Next Year
$38.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.54
52 Week High
$3.23
$1.28

Technical Indicators

Market Signals
Indicator
CLGN
NEXR
Relative Strength Index (RSI) 41.85 48.93
Support Level $0.31 $0.54
Resistance Level $0.45 $1.28
Average True Range (ATR) 0.05 0.17
MACD 0.00 -0.00
Stochastic Oscillator 31.38 13.38

Price Performance

Historical Comparison
CLGN
NEXR

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

About NEXR Nexera Technologies Ltd Ordinary Shares

Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.

Share on Social Networks: